1. Home
  2. RPRX vs UHAL Comparison

RPRX vs UHAL Comparison

Compare RPRX & UHAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • UHAL
  • Stock Information
  • Founded
  • RPRX 1996
  • UHAL 1945
  • Country
  • RPRX United States
  • UHAL United States
  • Employees
  • RPRX N/A
  • UHAL N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • UHAL Rental/Leasing Companies
  • Sector
  • RPRX Health Care
  • UHAL Consumer Discretionary
  • Exchange
  • RPRX Nasdaq
  • UHAL Nasdaq
  • Market Cap
  • RPRX 13.9B
  • UHAL 11.9B
  • IPO Year
  • RPRX 2020
  • UHAL N/A
  • Fundamental
  • Price
  • RPRX $36.03
  • UHAL $60.14
  • Analyst Decision
  • RPRX Strong Buy
  • UHAL
  • Analyst Count
  • RPRX 3
  • UHAL 0
  • Target Price
  • RPRX $47.33
  • UHAL N/A
  • AVG Volume (30 Days)
  • RPRX 4.3M
  • UHAL 135.4K
  • Earning Date
  • RPRX 08-07-2025
  • UHAL 08-06-2025
  • Dividend Yield
  • RPRX 2.44%
  • UHAL N/A
  • EPS Growth
  • RPRX 37.60
  • UHAL N/A
  • EPS
  • RPRX 2.45
  • UHAL 1.87
  • Revenue
  • RPRX $2,263,845,000.00
  • UHAL $5,828,665,000.00
  • Revenue This Year
  • RPRX $29.35
  • UHAL $5.55
  • Revenue Next Year
  • RPRX $7.58
  • UHAL $4.94
  • P/E Ratio
  • RPRX $14.72
  • UHAL $32.41
  • Revenue Growth
  • RPRX 1.13
  • UHAL 3.61
  • 52 Week Low
  • RPRX $24.05
  • UHAL $56.28
  • 52 Week High
  • RPRX $36.32
  • UHAL $79.04
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 64.81
  • UHAL 37.23
  • Support Level
  • RPRX $35.01
  • UHAL $60.34
  • Resistance Level
  • RPRX $36.14
  • UHAL $61.88
  • Average True Range (ATR)
  • RPRX 0.70
  • UHAL 1.20
  • MACD
  • RPRX 0.10
  • UHAL -0.23
  • Stochastic Oscillator
  • RPRX 90.07
  • UHAL 0.00

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About UHAL U-Haul Holding Company

U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.

Share on Social Networks: